Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Retained Earnings (2016 - 2024)

Historic Retained Earnings for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to -$40.2 million.

  • Zepp Health's Retained Earnings fell 13958.84% to -$40.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$40.2 million, marking a year-over-year decrease of 13958.84%. This contributed to the annual value of -$40.2 million for FY2024, which is 13850.27% down from last year.
  • Zepp Health's Retained Earnings amounted to -$40.2 million in Q4 2024, which was down 13958.84% from $101.5 million recorded in Q4 2023.
  • Zepp Health's Retained Earnings' 5-year high stood at $198.8 million during Q4 2021, with a 5-year trough of -$40.2 million in Q4 2024.
  • Moreover, its 5-year median value for Retained Earnings was $132.6 million (2022), whereas its average is $112.7 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 3236.83% in 2020, then crashed by 13958.84% in 2024.
  • Over the past 5 years, Zepp Health's Retained Earnings (Quarter) stood at $171.0 million in 2020, then rose by 16.26% to $198.8 million in 2021, then tumbled by 33.32% to $132.6 million in 2022, then fell by 23.44% to $101.5 million in 2023, then plummeted by 139.59% to -$40.2 million in 2024.
  • Its Retained Earnings stands at -$40.2 million for Q4 2024, versus $101.5 million for Q4 2023 and $132.6 million for Q4 2022.